RegStem

Developed for: osteoarthritis, knee
Investigated by: EMO Biomedicine Corporation · Far Eastern Memorial Hospital

today NCT03007576 · Ph 1

2018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03007576	Aug 2017 → Aug 2019	osteoarthritis, knee	EMO Biomedicine Corporation	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	RegStem	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03007576 ↗